The executive sold 15,051 shares for a total transaction value of ~$1.0 million at $69.63 per share.
The transaction size represented 3% of the direct equity holdings held prior to the filing.
The disposition was performed after Rocket Lab stock rose 54% over the trailing 12 months.
Dr. Marvin Bradford Clevenger, President of Rocket Lab USA, sold 15,051 shares of Rocket Lab Corporation (NASDAQ:RKLB) on August 24, 2026 as reported in a recent SEC Form 4 filing.
| Metric | Value |
|---|---|
| Transaction value | $1.0 million |
| Shares sold | 15,051 |
| Post-transaction shares (directly held) | 458,924 |
| Post-transaction value | $31.34 million |
Transaction value based on SEC Form 4 weighted average sale price ($69.63); post-transaction value based on August 24, 2026 market close ($68.28).
| Metric | Value |
|---|---|
| Share Price (as of market close 2026-08-25) | $66.91 |
| Market Capitalization | $38.7 billion |
| Revenue (TTM) | $769.1 million |
| Net Income (TTM) | -$165.5 million |
Rocket Lab Corporation, headquartered in Long Beach, California, operates as a prominent aerospace and defense enterprise. The company has established itself as a key provider of dedicated launch services and end-to-end space infrastructure solutions, serving both government and commercial markets.
With a market cap of $38.7 billion, Rocket Lab demonstrates significant scale within the aerospace sector, positioning itself as a critical enabler of space access for institutional and commercial stakeholders.
The August 24 sale of Rocket Lab stock by Dr. Clevenger is not a cause for investor concern. It was a non-discretionary event executed to fulfill tax withholding requirements connected with the vesting of RSUs.
An RSU is a form of compensation where a company grants an employee shares of stock at a future date. When that vesting date arrives, as was the case here, a "sell to cover" transaction occurs to pay the related taxes.
Rocket Lab stock has delivered strong returns over the past year thanks to contract wins that delivered an impressive 62% year-over-year increase in revenue to $234 million in the second quarter. It also reported a record backlog of orders totaling $2.4 billion. That's a whopping 137% increase from Q2 of 2025.
In addition, the company is planning to acquire Iridium, which would give Rocket Lab a constellation of low-Earth-orbit satellites that handle phone calls and text messaging anywhere on the planet.
Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this.
On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about to pop. If you’re worried you’ve already missed your chance to invest, now is the best time to buy before it’s too late. And the numbers speak for themselves:
Right now, we’re issuing “Double Down” alerts for three incredible companies, available when you join Stock Advisor, and there may not be another chance like this anytime soon.
See the 3 stocks »
*Stock Advisor returns as of August 30, 2026.
Robert Izquierdo has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Rocket Lab. The Motley Fool has a disclosure policy.